Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT03242915
Title Pembrolizumab in Combination With Platinum-Based Chemotherapy in Non-Small Cell Lung Cancer (NSCLC) Patients With Targetable Genetic Alterations, Previously Treated With Appropriate Targeted Agents, With Progressive Disease
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors University of Michigan Rogel Cancer Center
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Rush University Medical Center Chicago Illinois 60612 United States Details
The University of Michigan Comprehensive Cancer Center Ann Arbor Michigan 48109 United States Details
Barbara Ann Karmanos Cancer Institute Detroit Michigan 48201 United States Details
Henry Ford Cancer Institute/Henry Ford Hospital Detroit Michigan 48202 United States Details
Montefiore Cancer Center Bronx New York 10467 United States Details
Cleveland Clinic Cleveland Ohio 44195 United States Details
Sarah Cannon Nashville Tennessee 37203 United States Details
*Shaded cells indicate that there was no data available from for the field